Nanobiotix Seals a Non-dilutive Royalty Financing Agreement for Up to $71 Million
December 05, 2025
December 05, 2025
BOSTON, Massachusetts, Dec. 5 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Nanobiotix Seals a Non-dilutive Royalty Financing Agreement for Up to $71 Million
*
The Paris Life Sciences team advises Nanobiotix (Euronext: NANO NASDAQ: NBTX), on a non-dilutive royalty financing agreement with HealthCare Royalty (HCRx) for up to $71 million, in exchange of a portion of royalties from the sales of the produ . . .
* * *
Nanobiotix Seals a Non-dilutive Royalty Financing Agreement for Up to $71 Million
*
The Paris Life Sciences team advises Nanobiotix (Euronext: NANO NASDAQ: NBTX), on a non-dilutive royalty financing agreement with HealthCare Royalty (HCRx) for up to $71 million, in exchange of a portion of royalties from the sales of the produ . . .
